BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 10895816)

  • 1. Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumors.
    Bourgeois JM; Knezevich SR; Mathers JA; Sorensen PH
    Am J Surg Pathol; 2000 Jul; 24(7):937-46. PubMed ID: 10895816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma.
    Rubin BP; Chen CJ; Morgan TW; Xiao S; Grier HE; Kozakewich HP; Perez-Atayde AR; Fletcher JA
    Am J Pathol; 1998 Nov; 153(5):1451-8. PubMed ID: 9811336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma.
    Knezevich SR; McFadden DE; Tao W; Lim JF; Sorensen PH
    Nat Genet; 1998 Feb; 18(2):184-7. PubMed ID: 9462753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital-infantile fibrosarcoma. A clinicopathologic study of 10 cases and molecular detection of the ETV6-NTRK3 fusion transcripts using paraffin-embedded tissues.
    Sheng WQ; Hisaoka M; Okamoto S; Tanaka A; Meis-Kindblom JM; Kindblom LG; Ishida T; Nojima T; Hashimoto H
    Am J Clin Pathol; 2001 Mar; 115(3):348-55. PubMed ID: 11242790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced sensitivity of paraffin-based RT-PCR assays for ETV6-NTRK3 fusion transcripts in morphologically defined infantile fibrosarcoma.
    Argani P; Fritsch MK; Shuster AE; Perlman EJ; Coffin CM
    Am J Surg Pathol; 2001 Nov; 25(11):1461-4. PubMed ID: 11684968
    [No Abstract]   [Full Text] [Related]  

  • 6. ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma.
    Knezevich SR; Garnett MJ; Pysher TJ; Beckwith JB; Grundy PE; Sorensen PH
    Cancer Res; 1998 Nov; 58(22):5046-8. PubMed ID: 9823307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors.
    Argani P; Fritsch M; Kadkol SS; Schuster A; Beckwith JB; Perlman EJ
    Mod Pathol; 2000 Jan; 13(1):29-36. PubMed ID: 10658907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-resectable congenital tumors with the ETV6-NTRK3 gene fusion are highly responsive to chemotherapy.
    McCahon E; Sorensen PH; Davis JH; Rogers PC; Schultz KR
    Med Pediatr Oncol; 2003 May; 40(5):288-92. PubMed ID: 12652616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ETV6-NTRK3 gene fusion in metastasizing congenital fibrosarcoma.
    Punnett HH; Tomczak EZ; Pawel BR; de Chadarevian JP; Sorensen PH
    Med Pediatr Oncol; 2000 Aug; 35(2):137-9. PubMed ID: 10918240
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular mesoblastic nephroma: morphologic, cytogenetic and molecular links with congenital fibrosarcoma.
    Henno S; Loeuillet L; Henry C; D'Hervé D; Azzis O; Ferrer J; Poulain P; Babut JM; Merlio JP; Jouan H; Dubus P
    Pathol Res Pract; 2003; 199(1):35-40. PubMed ID: 12650516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptic t(12;15)(p13;q26) producing the ETV6-NTRK3 fusion gene and no loss of IGF2 imprinting in congenital mesoblastic nephroma with trisomy 11: fluorescence in situ hybridization and IGF2 allelic expression analysis.
    Watanabe N; Kobayashi H; Hirama T; Kikuta A; Koizumi S; Tsuru T; Kaneko Y
    Cancer Genet Cytogenet; 2002 Jul; 136(1):10-6. PubMed ID: 12165445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells.
    Wai DH; Knezevich SR; Lucas T; Jansen B; Kay RJ; Sorensen PH
    Oncogene; 2000 Feb; 19(7):906-15. PubMed ID: 10702799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis.
    Alaggio R; Barisani D; Ninfo V; Rosolen A; Coffin CM
    Pediatr Dev Pathol; 2008; 11(5):355-62. PubMed ID: 19006426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second Report of
    Hughes CE; Correa H; Benedetti DJ; Smith B; Sumegi J; Bridge J
    Pediatr Dev Pathol; 2021; 24(6):554-558. PubMed ID: 34120511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infantile NTRK-associated Mesenchymal Tumors.
    Davis JL; Lockwood CM; Albert CM; Tsuchiya K; Hawkins DS; Rudzinski ER
    Pediatr Dev Pathol; 2018; 21(1):68-78. PubMed ID: 28683589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
    Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
    Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological findings of pediatric NTRK fusion mesenchymal tumors.
    Kang J; Park JW; Won JK; Bae JM; Koh J; Yim J; Yun H; Kim SK; Choi JY; Kang HJ; Kim WS; Shin JH; Park SH
    Diagn Pathol; 2020 Sep; 15(1):114. PubMed ID: 32957984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy.
    Church AJ; Calicchio ML; Nardi V; Skalova A; Pinto A; Dillon DA; Gomez-Fernandez CR; Manoj N; Haimes JD; Stahl JA; Dela Cruz FS; Tannenbaum-Dvir S; Glade-Bender JL; Kung AL; DuBois SG; Kozakewich HP; Janeway KA; Perez-Atayde AR; Harris MH
    Mod Pathol; 2018 Mar; 31(3):463-473. PubMed ID: 29099503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.